Term ends Feb 7, 2037 · Medium confidence
20-year base term ends Feb 7, 2037
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,016,407, US 10,149,843, US 10,231,961, US 10,420,760), so the cap could be lower.
Feb 7, 2017
Feb 7, 2037
Jun 22, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 7, 2017, when application 15/427,011, the earliest non-provisional in its chain, was filed (this one was filed Oct 30, 2018) | Feb 7, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,016,407, US 10,149,843, US 10,231,961, US 10,420,760, US 9,867,815) | resolves to Feb 7, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 7, 2037 | Medium confidence |
This family
| US 10,149,843 | In force no later than Feb 2037 | no later than Feb 2037 |
| US 10,231,961 | In force no later than Feb 2037 | no later than Feb 2037 |
| US 9,867,815 | In force Feb 2037 | Feb 2037 |
| US 10,016,407 | In force no later than Feb 2037 | no later than Feb 2037 |
| US 10,413,505 | In force no later than Feb 2037 | no later than Feb 2037 |
| US 10,420,760 | In force no later than Feb 2037 | no later than Feb 2037 |
| US 11,040,032 | this patent Feb 2037 | Feb 2037 |
| US 10,987,347 | In force Feb 2037 | Feb 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 5, 2018 Reel 47682, frame 18 | Moshal, Jeffrey M.; Libman, Michael | Genus Lifesciences Inc. | Assignment of Assignor's Interest |
| Mar 16, 2023 Reel 62999, frame 559 | Genus Lifesciences Inc. | Noden Pharma Designated Activity Company | Assignment of Assignor's Interest |
| Dec 10, 2025 Reel 73940, frame 952 | Noden Pharma Designated Activity Company | Lxo Ireland Designated Activity Company | Change of Name |
| Apr 27, 2026 Reel 74483, frame 163 | Lxo Ireland Designated Activity Company | Kroll Trustee Services Limited, as Security Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,016,407, US 10,149,843, US 10,231,961, US 10,420,760, US 9,867,815, ends no earlier than this term, so it caps nothing.